-
EP1971366
European procedure
Extract from the Register of European Patents
EP About this file: EP1971366
| EP1971366 - HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.06.2015 Database last updated on 07.04.2026 | Most recent event Tooltip | 05.06.2015 | No opposition filed within time limit | published on 08.07.2015 [2015/28] | Applicant(s) | For all designated states Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US | [2011/44] |
| Former [2009/33] | For all designated states Centocor Ortho Biotech Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US | ||
| Former [2008/39] | For all designated states CENTOCOR, INC. 200 Great Valley Parkway Malvern, PA 19355 / US | Inventor(s) | 01 /
BENSON, Jacqueline 5 Oak Glen Drive Malvern, PA 19355 / US | 02 /
CARTON, Jill 3787 Kratz Road Collegeville, PA 19426 / US | 03 /
CUNNINGHAM, Mark 716 Garden Drive Kennett Square, PA 19348 / US | 04 /
ORLOVSKY, Yevgeniya, I. 2804 Century Lane Chadds Ford, PA 19317 / US | 05 /
RAUCHENBERGER, Robert Esterbergstrasse 9 82490 Farchant / DE | 06 /
SWEET, Raymond 700 Oak Spring Road Bryn Mawr, PA 19010 / US | [2008/39] | Representative(s) | Marshall, Cameron John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2014/31] |
| Former [2009/51] | Marshall, Cameron John Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
| Former [2008/39] | Marshall, Cameron John Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 06846836.2 | 28.12.2006 | [2008/39] | WO2006US62674 | Priority number, date | US20050754889P | 29.12.2005 Original published format: US 754889 P | [2008/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007076524 | Date: | 05.07.2007 | Language: | EN | [2007/27] | Type: | A2 Application without search report | No.: | EP1971366 | Date: | 24.09.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.07.2007 takes the place of the publication of the European patent application. | [2008/39] | Type: | B1 Patent specification | No.: | EP1971366 | Date: | 30.07.2014 | Language: | EN | [2014/31] | Search report(s) | International search report - published on: | US | 27.03.2008 | (Supplementary) European search report - dispatched on: | EP | 26.02.2010 | Classification | IPC: | C07K16/24, A61K39/00 | [2014/11] | CPC: |
C07K16/244 (EP,EA,US);
A61K39/3955 (EA,NO,US);
C07K16/18 (KR);
C07K16/24 (EA,NO);
A61J1/00 (EA);
A61K39/395 (EA,KR);
A61K47/183 (EA,NO);
A61K47/26 (EA,NO,US);
A61K9/0019 (EA,NO,US);
A61K9/08 (EA,NO,US);
A61P1/00 (EP,EA);
A61P1/04 (EP,EA);
A61P11/00 (EP,EA);
A61P17/06 (EP,EA);
A61P17/08 (EP,EA);
A61P19/02 (EP,EA);
A61P25/00 (EP,EA);
A61P25/02 (EP,EA);
A61P27/02 (EP,EA);
A61P29/00 (EP,EA);
A61P31/00 (EP,EA);
A61P35/00 (EP,EA);
A61P37/00 (EP,EA);
A61P37/02 (EP,EA);
A61P9/00 (EP,EA);
C07K16/00 (KR);
C07K16/42 (EA);
C12N15/63 (EA);
C12N5/10 (EA);
G01N33/567 (KR);
A61K2039/505 (EP,EA,US);
C07K2317/21 (EP,EA,US);
C07K2317/34 (EP,EA,US);
C07K2317/52 (EP,EA,US);
C07K2317/55 (EP,EA,US);
C07K2317/565 (EP,EA,US);
C07K2317/73 (EP,EA,US);
C07K2317/76 (EP,EA,US);
C07K2317/92 (EP,EA,US);
|
| Former IPC [2013/46] | C07K16/24 | ||
| Former IPC [2008/39] | A61K39/395, G01N33/567 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/39] | Extension states | AL | 28.07.2008 | BA | 28.07.2008 | HR | 28.07.2008 | MK | 28.07.2008 | RS | 28.07.2008 | Title | German: | MENSCHLICHE ANTI-IL-23-ANTIKÖRPER, ZUSAMMENSETZUNGEN, VERFAHREN UND VERWENDUNGEN | [2008/39] | English: | HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES | [2008/39] | French: | ANTICORPS HUMAINS ANTI-IL-23, COMPOSITIONS, PROCEDES ET UTILISATIONS AFFERENTS | [2008/39] | Entry into regional phase | 28.07.2008 | National basic fee paid | 28.07.2008 | Search fee paid | 28.07.2008 | Designation fee(s) paid | 28.07.2008 | Examination fee paid | Examination procedure | 28.07.2008 | Amendment by applicant (claims and/or description) | 28.07.2008 | Examination requested [2008/39] | 22.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 08.02.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 19.04.2011 | Reply to a communication from the examining division | 23.12.2011 | Despatch of a communication from the examining division (Time limit: M06) | 28.06.2012 | Reply to a communication from the examining division | 12.12.2012 | Despatch of a communication from the examining division (Time limit: M04) | 20.02.2013 | Reply to a communication from the examining division | 02.12.2013 | Communication of intention to grant the patent | 13.01.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 17.02.2014 | Communication of intention to grant the patent | 17.06.2014 | Fee for grant paid | 17.06.2014 | Fee for publishing/printing paid | 17.06.2014 | Receipt of the translation of the claim(s) | Divisional application(s) | EP12174197.9 / EP2548577 | EP17156111.1 / EP3219328 | EP20180279.0 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.06.2010 | Opposition(s) | 04.05.2015 | No opposition filed within time limit [2015/28] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 15.04.2011 | Request for further processing filed | 15.04.2011 | Full payment received (date of receipt of payment) Request granted | 03.05.2011 | Decision despatched | Fees paid | Renewal fee | 28.07.2008 | Renewal fee patent year 03 | 11.12.2009 | Renewal fee patent year 04 | 15.12.2010 | Renewal fee patent year 05 | 12.12.2011 | Renewal fee patent year 06 | 11.12.2012 | Renewal fee patent year 07 | 12.12.2013 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y] US2004223969 (OFT MARTIN et al.) [Y] 1-27 * see § 103 and table 2 * | [Y] WO2005108425 (CYTOS BIOTECHNOLOGY AG et al.) [Y] 1-27 * examples 7,11-14 * | International search | [X] US2005137385 (BENSON JACQUELINE et al.) [X] | [A] US2004156849 (GURNEY AUSTIN L et al.) [A] | [A] US2004185506 (HEAVNER GEORGE A et al.) [A] | [A] US2005049402 (BABCOOK JOHN S et al.) [A] | [A] US2003124617 (GRAM HERMANN et al.) [A] | [A] US2002042386 (ROSEN CRAIG A et al.) [A] | Examination | SOFEN H., ET AL: "Results of a single ascending dose study to assess the safety and tolerability of CNTO 1959 following intravenous or subcutaneous administration in healthy subjects and in subjects with moderate to severe psoriasis.", BRITISH ASSOCIATION OF DERMATOLOGISTS, no. 165, 1 January 2011 (2011-01-01), pages E1 - E46 |